Literature DB >> 17255837

Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.

Rubén E Quirós-Tejeira1, Chantal A Rivera, Taonga T Ziba, Nitesh Mehta, C Wayne Smith, Nancy F Butte.   

Abstract

OBJECTIVES: To characterize children at risk for nonalcoholic fatty liver disease (NAFLD) and to explore possible mechanisms underlying the development of NAFLD in Hispanic youth with a body mass index > or =95th percentile. PATIENTS AND METHODS: Hispanic nonoverweight (n = 475) and overweight (n = 517) children, ages 4 to 19 y, were characterized in terms of body composition (dual-energy x-ray absorptiometry), maturation (Tanner stage), diet (24-h recall), physical activity (accelerometry), fitness (maximal oxygen uptake), and biochemical profile (fasting alanine aminotransferase [ALT], glucose, insulin, and lipids; inflammation markers such as adiponectin, leptin, C-reactive protein, and soluble intercellular adhesion molecule-1; and total antioxidants) using standard laboratory techniques. Risk for NAFLD was defined by fasting serum ALT values >97.5th percentile for age- and sex-specific reference values.
RESULTS: Fasting serum ALT was elevated in 24% of overweight children and in only 4% of nonoverweight children. Therefore, to identify risk factors associated with elevated ALT, the remaining statistical analysis was restricted to the overweight group. The percentage of overweight children with elevated ALT did not differ by sex, age, or Tanner stage. Weight, body mass index, z score, waist-to-hip ratio, fat-free mass, fat mass, and percent truncal fat mass were higher in the overweight children with elevated ALT. Fasting insulin, glucose, and homeostasis model-insulin resistance were higher in the overweight children with elevated ALT, as were triglycerides, total cholesterol, low-density lipoprotein, thyroid-stimulating hormone, and triiodothyronine. Fasting serum leptin, C-reactive protein, and soluble intercellular adhesion molecule-1 were significantly higher and adiponectin was lower in the overweight children with elevated ALT.
CONCLUSIONS: The risk for developing NAFLD was high in the overweight Hispanic children. The proportion of "at risk" children was not influenced by gender, age, or maturation. The risk for elevated ALT was predicted by the severity of obesity, central adiposity, hyperinsulinemia, hypertriglyceridemia, elevated thyroid-stimulating hormone, and systemic inflammation.

Entities:  

Mesh:

Year:  2007        PMID: 17255837     DOI: 10.1097/MPG.0b013e31802d4acc

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  40 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Fatty liver disease in children: eat now pay later.

Authors:  Ruth M L De Bruyne; Emer Fitzpatrick; Anil Dhawan
Journal:  Hepatol Int       Date:  2010-01-29       Impact factor: 6.047

Review 3.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 4.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

5.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

6.  A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase.

Authors:  Ping-Hao Chen; Jong-Dar Chen; Yu-Cheng Lin
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

7.  Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.

Authors:  David E St-Jules; Corilee A Watters; Elizabeth M Brunt; Lynne R Wilkens; Rachel Novotny; Patricia Belt; Joel E Lavine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

Review 8.  Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Elizabeth L Yu; Jeffrey B Schwimmer
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 9.  The metabolic syndrome and nonalcoholic fatty liver disease in children.

Authors:  Shikha S Sundaram; Phil Zeitler; Kristen Nadeau
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856

10.  Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents.

Authors:  Roya Kelishadi; Stephen R Cook; Atoosa Adibi; Zahra Faghihimani; Shohreh Ghatrehsamani; Abolfazl Beihaghi; Hamidreza Salehi; Noushin Khavarian; Parinaz Poursafa
Journal:  Diabetol Metab Syndr       Date:  2009-12-22       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.